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ABSTRACT
We report four adult cases of atopic dermatitis (AD) complicated by Sjögren’s syndrome (SS). The patients ful-
filled diagnostic criteria for AD and SS. All cases showed persistent itchy dry skin and eczematous lesions com-
plicated by sicca symptoms including dry eyes and dry mouth with moderate joint pain. One case manifested
annular erythema and another manifested widespread discoid erythema. To investigate the underlying cause of
dry skin in these cases, sweating function was evaluated using a quantitative sudomotor axon reflex test
(QSART) in which the axon reflex is stimulated by acetylcholine iontophoresis. The sweating latency time was
significantly prolonged in eczematous skin of AD and ADSS compared to normal controls. Axon reflex (AXR)
sweat volume was also significantly reduced in AD (normal and eczematous skin) and ADSS (normal and ec-
zema) compared to normal control. In contrast, the direct sweat volume of lesional or non-lesional AD skin in-
duced by direct stimulation with acetylcholine was only slightly reduced compared to that in normal controls, but
not in SS and lesional skin of ADSS patients. These results suggest that the impaired sweat response in AD is
attributable to an abnormal sudomotor axon reflex, which is accelerated and modulated when complicated by
SS resulting in dry skin in the present cases.
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INTRODUCTION
Dry skin, immunological dysfunction, increased IgE
production, and an autonomic nervous system imbal-
ance are frequently observed in patients with atopic
dermatitis (AD), along with bronchial asthma or pol-
lenosis, which have closely related genetic risk fac-
tors. Recent reports suggest that common loss-of-
function variants of the epidermal barrier protein
filaggrin are major genetic risk factors for AD.1-3
Sjögren’s syndrome (SS), another representative
autoimmune disease with hypohidorosis, also mani-
fests dry skin and might exacerbate dry skin in the
setting of AD. Although the prevalence of AD and SS
in the general population is not low, complication of
these diseases has been rarely documented. We re-
port sweat function in four cases of AD associated
with SS (ADSS).
CLINICAL SUMMARY
All patients fulfilled the diagnostic criteria for AD4
and SS,5 including moderate to severe, persistent
itchy skin lesions and sicca symptoms of dry eyes
and dry mouth with moderate joint pain. One case
manifested annular erythema and another manifested
widespread discoid erythema. Clinical profiles of the
four patients are described in Table 1, 2, and clinical
features are shown in Figure 1. The profile of Case 3
was described elsewhere.6
With the Institutional Review Board approval, a
Allergology International. 2011;60:387-391
CASE REPORT
1Department of Dermatology Integrated Medicine, Graduate
School of Medicine Osaka University, Osaka, Japan.
Correspondence: Ichiro Katayama, Department of Dermatology In-
tegrated Medicine, Graduate School of Medicine Osaka Univer-
sity, 2−2 Yamada-Oka, Suita-shi, Osaka 565−0871, Japan.
Email: katayama@derma.med.osaka−u.ac.jp
Received 6 September 2010. Accepted for publication 22 October
2010.
2011 Japanese Society of Allergology
DOI: 10.2332allergolint.10-CR-0265
Kitaba S et al.
388 Allergology International Vol 60, No3, 2011 www.jsaweb.jp
Table　1　Clinical data related to atopic dermatitis
Case No. Age Gender SCORAD TARC (pg/ml) IgE-RIST (IU/L) Eosinophil (%) Eosinophil (mm3)
1 29 female 35.2 497 298 3.7 192
2 32 female 49.5 1,596 6,790 14.1 1,112
3 32 female 60.3 2,363 15,300 6.3 306
4 17 male 25.3 224 124 7.3 392
SCORAD, severity scoring of atopic dermatitis; TARC, Thymus and activation regulated chemokine/CCL17 (pg/ml: normal < 400).
Table　2　Clinical data related to Sjögren’s syndrome
Case 
No.
Schirmer’s 
test
Conjunc-
tivitis
Lip biopsy 
(grade)
Gum test 
(ml/10 
minutes)
Positive fi ndings 
of salivary gland 
scintigram
Anti-S
SA ab 
(U/ml)
Anti-S
SB ab 
(U/ml)
IgG 
(mg/dl) ANA
Anti DNA ab 
(IU/ml)
1 + + ND 5 - - 62.1 1,633 - -
2 + + ND 8 + 101 41.7 2,178 ×80 -
3 + + 3 8 + 68 - 4,478 ×80 -
4 - - 3 9 ND 122 183 1,727 ×1280 -
ND, not done; ab, antibody.
Fig.　1　Clinical appearance of the patients. (A) Patient 1: Li-
chenifi ed and crusted lesions are present on the cubital fossa 
and wrist, (B) Patient 2: Diffuse erythema and lichenifi ed ec-
zematous lesions are observed on the trunk skin, (C) Patient 
3: Diffuse erythematous scaly patches with crusted and pap-
ular eruptions were observed on her face, scalp, and dorsal
aspect of the hands, and (D) Patient 4: Pruriginous crusted 
papules are present on the back.
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quantitative sudomotor axon reflex test (QSART) in
which the axon reflex is stimulated by acetylcholine
iontophoresis was performed as described previ-
ously.7 Briefly, the subjects were asked to remain
quiet in the measurement room before undergoing
QSART. The two-channel type perspirometer (POS-
02, Skinos, Co. Ltd., Nagoya, Japan) was used for the
measurement of sweat volume. Acetylcholine
induced-QSART (AXR sweating) was measured after
iontophoretical application of acetylcholine (100 mg
ml) to the skin from the outer capsule using CI-5.0
(Skinos, Co.Ltd.). AXR sweat volume in the inner cap-
sule separated by plastic wall from outer capsule was
measured during 5 min of iontophoresis. Data for
DIR sweating were obtained over the subsequent 5
min. Sweat onset time, i.e., the latency period from
current loading to sweating (latency time), and sweat
volume over 5 min were measured, and the area un-
der the sweating curve was calculated during 0-5 min
for AXR sweating and 6-11 min for DIR sweating (Ta-
ble 3).
The latency time was significantly prolonged in AD
(eczema) and ADSS (eczema) compared to normal
controls (N, Fig. 2) and AXR sweat volume was also
significantly reduced in AD (normal and eczema) and
ADSS (normal and eczema) compared to normal
controls (N, Fig. 3). In contrast, the DIR sweat vol-
ume of lesional or non-lesional AD skin was only
slightly reduced compared to that in non-atopic con-
trols, but that of lesional skin of ADSS was appar-
ently decreased without statistical significance (Fig.
4). These results suggest that the impaired sweat re-
sponse in AD is attributable to an abnormal sudomo-
tor axon reflex, which is accelerated and modulated
when complicated by SS.
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Table　3　Measured values in quantitative sweat tests
Case No. Latency (NL) seconds
Latency (L) 
seconds
AXR (NL) 
mg/5 minutes
AXR (L) 
mg/5 minutes
DIR (NL) 
mg/5 minutes
DIR (L) 
mg/5 minutes
1 107 143 0.145 0.354 1.224 0.735
2 143 155 0.314 0.367 1.775 2.801
3 170 161 0.353 0.388 2.455 0.975
4 120 300 0.785 0.040 6.839 0.543
NL, non-lesional skin; L, lesional skin.
Fig.　2　Quantitative sweating test. Quantitative sweating
test was performed as previously described.7 Latency period
(seconds) in normal skin (normal control, SS, AD, and AD/
SS) and lesional eczematous skin (AD and AD/SS). One-way
ANOVA was used for the statistical analysis. *p < 0.05. AD 
(eczema) to normal control (N), AD/SS (eczema) to normal 
control (N), AD (eczema) to SS, and AD/SS (eczema) to SS.
Number: case number.
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Fig.　3　Sweat volume of AXR in normal skin (normal con-
trol, SS, AD, and AD/SS) and lesional eczematous skin (AD 
and AD/SS). One-way ANOVA was used for the statistical 
analysis. *p < 0.05 AD to normal control (N) and AD/SS to
normal control (N). Number: case number.
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Fig.　4　Sweat volume of DIR in normal skin (normal control,
SS, AD, and AD/SS) and lesional eczematous skin (AD and 
AD/SS). Number: case number.
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DISCUSSION
Although the prevalence of adult atopic dermatitis in
Japan is 6.9%,8 complication of AD by SS is relatively
rare and few case reports are available in the litera-
ture except in the setting of SLE.9,10 The involvement
of Th17 cells in both SS11 and AD,12 as well as the
Th1 and Th2 balance theory are thought to be re-
sponsible for the rare complication of these allergic
and systemic autoimmune diseases. Although it is
conceivable that complication of two diseases is coin-
cident, recent reports suggest ANA positivity in
atopic dermatitis.13 Therefore Sjögren’s syndrome
might exist in this populations of atopic dermatitis.
We previously reported that sweating function is
impaired in patients with AD and primary SS com-
pared to normal controls.7,14 In SS, sweating induced
by both the direct action of acetylcholine and the
axon reflex is impaired, possibly due to eccrine gland
dysfunction resulting from autoimmune mechanisms
mediated by CD8 T cells15 or M3 receptor-specific
autoantibodies16 as previously described. In contrast
to SS, the reduced sweating function seen in AD is re-
stricted only to axon reflex-induced indirect sweating,
which is usually restored to normal levels after im-
provement of the dermatitis.7 Therefore, xerotic skin
lesions seen in the present cases might be due to ad-
ditive AD- and SS-related hypohidrosis with acceler-
ated dry skin. It is well known that dry skin is occa-
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sionally seen in SS and clinical use of muscarinic M3
receptor agonists occasionally improves this condi-
tion through recovery of sweating function.17
In regard to the sweating function in AD, it is well
known that sweating may cause itching and secon-
dary eczema; however, the results of previous studies
on sweat-gland function in AD are controversial.
Sweat secretion has been reported to be de-
creased,18,19 increased,20,21 or normal22 in various ex-
perimental studies of AD. Our previous observation
on sweating function using QSART clearly demon-
strated that reversible impairment of sweating func-
tion is present in AD. Most previous investigations as-
sessed sweating function using a direct stimulation
sweating test in which intradermal acetylcholine in-
jection resulted in direct sweat responses.17-19 To clar-
ify sweat function in AD, we evaluated the postgangli-
onic sweat output, which reflects axon reflex-
mediated sweating function, using QSART. In the
present cases, AXR sweat volumes were reduced and
latency time prolonged in both non-lesional and le-
sional skin of ADSS patients compared to those in
non-atopic controls, and the reduction was greater in
ADSS. In contrast to patients with AD, the DIR re-
sponse characterized by exocrine gland dysfunction
in patients with SS,14,23,24 was significantly reduced
compared to that in normal AD skin or healthy con-
trols. The reason for normal DIR in normal skin of
ADSS patient is unclear at present. The presence of
atopic skin lesions may modulate sweating function
in normal skin of ADSS by possible compensatory
mechanisms.
Recent reports have suggested that the barrier
function, including TEWL, recovers or that ceramide
content in the stratum corneum return to normal lev-
els when eczematous changes resolve.25,26 Possible
tolerance to cholinergic stimulation, manifesting as a
higher sudomotor nerve excitation threshold or nega-
tive feedback, may be controlled in patients with se-
vere AD by psychosomatic or unknown factors that
could be therapeutic targets in adults with refractory
disease. Although complication of AD by SS disease
has been rarely documented, it might be underesti-
mated or overlooked in daily practice. For the skin
care in AD, the complication of SS should be moni-
tored, especially in adult AD patients.
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